🇺🇸 isophane human insulin in United States

32 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Conjoined Twins — 8 reports (25%)
  2. Foetal Exposure During Pregnancy — 7 reports (21.88%)
  3. Maternal Exposure During Pregnancy — 3 reports (9.38%)
  4. Acute Kidney Injury — 2 reports (6.25%)
  5. Acute Respiratory Failure — 2 reports (6.25%)
  6. Blood Glucose Increased — 2 reports (6.25%)
  7. Cardio-Respiratory Arrest — 2 reports (6.25%)
  8. Congenital Bladder Anomaly — 2 reports (6.25%)
  9. Cough — 2 reports (6.25%)
  10. Drug Interaction — 2 reports (6.25%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is isophane human insulin approved in United States?

isophane human insulin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for isophane human insulin in United States?

Novo Nordisk A/S is the originator. The local marketing authorisation holder may differ — check the official source linked above.